Clinical Trial Update: A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML [Phase 1]

View source ↗

Summary

Phase I study evaluating 5-azacytidine in combination with chemotherapy for children with relapsed or refractory acute lymphoblastic leukemia or acute myeloid l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Children
• Acute Myeloid Leukemia in Children

Drugs mentioned

• 5-Azacytidine (5-azacytidine)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Lymphoblastic Leukemia, Acute, Childhood, Myelogenous Leukemia, Acute, Childhood | Phase 1 | Status: COMPLETED | Results posted: 2021-04-30